Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 68 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

12%

8 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

29 recruiting

Enrollment Performance

Analytics

N/A
27(56.3%)
Phase 2
10(20.8%)
Phase 4
5(10.4%)
Phase 1
3(6.3%)
Phase 3
3(6.3%)
48Total
N/A(27)
Phase 2(10)
Phase 4(5)
Phase 1(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (68)

Showing 20 of 68 trials
NCT07244978Phase 2Recruiting

Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

Role: lead

NCT06173115Not ApplicableCompleted

Comparison of a Single Versus Double Perclose Technique for TAVR

Role: lead

NCT04666090Phase 2Active Not Recruiting

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Role: lead

NCT07772401Not ApplicableRecruiting

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder

Role: lead

NCT06549829Not ApplicableCompleted

the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma

Role: lead

NCT07505186Phase 2Recruiting

Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

Role: lead

NCT07856355Phase 4Not Yet Recruiting

Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia

Role: lead

NCT07669155Not ApplicableNot Yet Recruiting

Acute Normovolemic Hemodilution in Bone Cancer Surgery

Role: lead

NCT05742204Active Not Recruiting

Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer

Role: lead

NCT07850947Not Yet Recruiting

An Observational Study of Percutaneous Glomerular Filtration Rate (TGFR) in the Early Warning of Contrast-induced Acute Kidney Injury During the Peri-examination Period of Emergency Enhanced CT

Role: lead

NCT07848984Phase 2Not Yet Recruiting

Chinese Herbal Acupoint Application Combined With Triple Antiemetic Therapy for Prevention of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer

Role: lead

NCT07804745Active Not Recruiting

Fertility Decision and Outcomes in Young Women With Breast Cancer

Role: lead

NCT07847580Not ApplicableNot Yet Recruiting

Intranasal Dexmedetomidine and Perioperative Myocardial Injury in Patients Having Percutaneous Coronary Interventions

Role: lead

NCT07846176Not Yet Recruiting

Aficamten and Patient-Reported Outcomes in Real-World nHCM

Role: lead

NCT07760051Not ApplicableRecruiting

Effects of Agent-assisted, LLM-assisted and Traditional Workflows on Diagnosis and Management Planning at Admission

Role: lead

NCT07380646Phase 2Recruiting

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Role: lead

NCT06742125Not ApplicableRecruiting

Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction

Role: lead

NCT07840794Not ApplicableNot Yet Recruiting

Stimulation-Temperature-Oxygen-Positioning Multimodal Neuroprotection for Acute Ischemic Stroke (STOP)

Role: lead

NCT06238232Not ApplicableCompleted

68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism: The GAPA Randomized Clinical Trial

Role: collaborator

NCT03957707Not ApplicableCompleted

Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation

Role: lead